ICON Health Publications
Official Health Sourcebooks
   
Search ICON Health Titles:      

 

The Official Patient's Sourcebook
on

SCLERODERMA

(Familial Progressive Systemic Sclerosis; Morphea; Progressive systemic sclerosis; Systemic Sclerosis)

 

Revised and Updated for the Internet Age

 

P

A

P

E

R

B

A

C

K

Paperback Book

Paperback Book

Order by phone:

800-843-2665 (within USA)

1-201-272-3651 (from outside USA)


E

B

O

O

K

 
Pages  :  288
Price  :  $28.95(USD)
ISBN  :  0597829896
Published  :  2002
 
 
   Synopsis
 

A comprehensive manual for anyone interested in self-directed research on scleroderma. Fully referenced with ample Internet listings and glossary.

 
   Related Conditions/Synonyms
 

Familial Progressive Systemic Sclerosis; Morphea; Progressive systemic sclerosis; Systemic Sclerosis

 
 

 Description

 

This book has been created for patients who have decided to make education and research an integral part of the treatment process. Although it also gives information useful to doctors, caregivers and other health professionals, it tells patients where and how to look for information covering virtually all topics related to scleroderma (also Familial Progressive Systemic Sclerosis; Morphea; Progressive systemic sclerosis; Systemic Sclerosis), from the essentials to the most advanced areas of research. The title of this book includes the word official. This reflects the fact that the sourcebook draws from public, academic, government, and peer-reviewed research. Selected readings from various agencies are reproduced to give you some of the latest official information available to date on scleroderma. Given patients' increasing sophistication in using the Internet, abundant references to reliable Internet-based resources are provided throughout this sourcebook. Where possible, guidance is provided on how to obtain free-of-charge, primary research results as well as more detailed information via the Internet. E-book and electronic versions of this sourcebook are fully interactive with each of the Internet sites mentioned (clicking on a hyperlink automatically opens your browser to the site indicated). Hard-copy users of this sourcebook can type cited Web addresses directly into their browsers to obtain access to the corresponding sites. In addition to extensive references accessible via the Internet, chapters include glossaries of technical or uncommon terms.

 

 

 Table of Contents

 

Introduction

Overview

Organization

Scope

Moving Forward

PART I: THE ESSENTIALS

Chapter 1. The Essentials on Scleroderma: Guidelines

Overview

What Is Scleroderma?

What Are the Different Types of Scleroderma?

Localized Scleroderma

Systemic Scleroderma (Also Known As Systemic Sclerosis)

What Causes Scleroderma?

Who Gets Scleroderma?

How Can Scleroderma Affect My Life?

How Is Scleroderma Diagnosed?

What Other Conditions Can Look Like Scleroderma?

How Is Scleroderma Treated?

How Can I Play a Role in My Health Care?

Is Research Close to Finding a Cure?

More Guideline Sources

Vocabulary Builder

Chapter 2. Seeking Guidance

Overview

Associations and Scleroderma

Finding More Associations

Finding Doctors

Finding a Dermatologist

Selecting Your Doctor

Working with Your Doctor

Broader Health-Related Resources

Vocabulary Builder

Chapter 3. Clinical Trials and Scleroderma

Overview

Recent Trials on Scleroderma

Benefits and Risks

Keeping Current on Clinical Trials

General References

Vocabulary Builder

PART II: ADDITIONAL RESOURCES AND ADVANCED MATERIAL

Chapter 4. Studies on Scleroderma

Overview

The Combined Health Information Database

Federally-Funded Research on Scleroderma

E-Journals: PubMed Central

The National Library of Medicine: PubMed

Vocabulary Builder

Chapter 5. Patents on Scleroderma

Overview

Patents on Scleroderma

Patent Applications on Scleroderma

Keeping Current

Vocabulary Builder

Chapter 6. Books on Scleroderma

Overview

Book Summaries: Federal Agencies

Book Summaries: Online Booksellers

The National Library of Medicine Book Index

Chapters on Scleroderma

General Home References

Vocabulary Builder

Chapter 7. Multimedia on Scleroderma

Overview

Video Recordings

Bibliography: Multimedia on Scleroderma

Vocabulary Builder

Chapter 8. Periodicals and News on Scleroderma

Overview

News Services & Press Releases

Newsletters on Scleroderma

Newsletter Articles

Academic Periodicals covering Scleroderma

Vocabulary Builder

Chapter 9. Physician Guidelines and Databases

Overview

NIH Guidelines

NIH Databases

Other Commercial Databases

The Genome Project and Scleroderma

Specialized References

Chapter 10. Dissertations on Scleroderma

Overview

Dissertations on Scleroderma

Keeping Current

PART III. APPENDICES

Appendix A. Researching Your Medications

Overview

Your Medications: The Basics

Learning More about Your Medications

Commercial Databases

Contraindications and Interactions (Hidden Dangers)

A Final Warning

General References

Vocabulary Builder

Appendix B. Researching Alternative Medicine

Overview

What Is CAM?

What Are the Domains of Alternative Medicine?

Can Alternatives Affect My Treatment?

Finding CAM References on Scleroderma

Additional Web Resources

General References

Appendix C. Researching Nutrition

Overview

Food and Nutrition: General Principles

Finding Studies on Scleroderma

Federal Resources on Nutrition

Additional Web Resources

Vocabulary Builder

Appendix D. Finding Medical Libraries

Overview

Preparation

Finding a Local Medical Library

Medical Libraries Open to the Public

Appendix E. Your Rights and Insurance

Overview

Your Rights as a Patient

Patient Responsibilities

Choosing an Insurance Plan

Medicare and Medicaid

NORD’s Medication Assistance Programs

Additional Resources

Vocabulary Builder

ONLINE GLOSSARIES

Online Dictionary Directories

SCLERODERMA GLOSSARY

General Dictionaries and Glossaries

INDEX

 
 

 Excerpt (Introduction)

 

Overview

Dr. C. Everett Koop, former U.S. Surgeon General, once said, “The best prescription is knowledge.” The Agency for Healthcare Research and Quality (AHRQ) of the National Institutes of Health (NIH) echoes this view and recommends that every patient incorporate education into the treatment process. According to the AHRQ:

Finding out more about your condition is a good place to start. By contacting groups that support your condition, visiting your local library, and searching on the Internet, you can find good information to help guide your treatment decisions. Some information may be hard to find—especially if you don't know where to look.

As the AHRQ mentions, finding the right information is not an obvious task. Though many physicians and public officials had thought that the emergence of the Internet would do much to assist patients in obtaining reliable information, in March 2001 the National Institutes of Health issued the following warning:

The number of Web sites offering health-related resources grows every day. Many sites provide valuable information, while others may have information that is unreliable or misleading.

Since the late 1990s, physicians have seen a general increase in patient Internet usage rates. Patients frequently enter their doctor's offices with printed Web pages of home remedies in the guise of latest medical research. This scenario is so common that doctors often spend more time dispelling misleading information than guiding patients through sound therapies. The Official Patient’s Sourcebook on Scleroderma has been created for patients who have decided to make education and research an integral part of the treatment process. The pages that follow will tell you where and how to look for information covering virtually all topics related to scleroderma, from the essentials to the most advanced areas of research.

The title of this book includes the word “official.” This reflects the fact that the sourcebook draws from public, academic, government, and peer-reviewed research. Selected readings from various agencies are reproduced to give you some of the latest official information available to date on scleroderma.

Given patients’ increasing sophistication in using the Internet, abundant references to reliable Internet-based resources are provided throughout this sourcebook. Where possible, guidance is provided on how to obtain free-of-charge, primary research results as well as more detailed information via the Internet. E-book and electronic versions of this sourcebook are fully interactive with each of the Internet sites mentioned (clicking on a hyperlink automatically opens your browser to the site indicated). Hard copy users of this sourcebook can type cited Web addresses directly into their browsers to obtain access to the corresponding sites. Since we are working with ICON Health Publications, hard copy Sourcebooks are frequently updated and printed on demand to ensure that the information provided is current.

In addition to extensive references accessible via the Internet, every chapter presents a “Vocabulary Builder.” Many health guides offer glossaries of technical or uncommon terms in an appendix. In editing this sourcebook, we have decided to place a smaller glossary within each chapter that covers terms used in that chapter. Given the technical nature of some chapters, you may need to revisit many sections. Building one’s vocabulary of medical terms in such a gradual manner has been shown to improve the learning process.

We must emphasize that no sourcebook on scleroderma should affirm that a specific diagnostic procedure or treatment discussed in a research study, patent, or doctoral dissertation is “correct” or your best option. This sourcebook is no exception. Each patient is unique. Deciding on appropriate options is always up to the patient in consultation with their physician and healthcare providers.

Organization

This sourcebook is organized into three parts. Part I explores basic techniques to researching scleroderma (e.g. finding guidelines on diagnosis, treatments, and prognosis), followed by a number of topics, including information on how to get in touch with organizations, associations, or other patient networks dedicated to scleroderma. It also gives you sources of information that can help you find a doctor in your local area specializing in treating scleroderma. Collectively, the material presented in Part I is a complete primer on basic research topics for patients with scleroderma.

Part II moves on to advanced research dedicated to scleroderma. Part II is intended for those willing to invest many hours of hard work and study. It is here that we direct you to the latest scientific and applied research on scleroderma. When possible, contact names, links via the Internet, and summaries are provided. It is in Part II where the vocabulary process becomes important as authors publishing advanced research frequently use highly specialized language. In general, every attempt is made to recommend “free-to-use” options.

Part III provides appendices of useful background reading for all patients with scleroderma or related disorders. The appendices are dedicated to more pragmatic issues faced by many patients with scleroderma. Accessing materials via medical libraries may be the only option for some readers, so a guide is provided for finding local medical libraries which are open to the public. Part III, therefore, focuses on advice that goes beyond the biological and scientific issues facing patients with scleroderma.

Scope

While this sourcebook covers scleroderma, your doctor, research publications, and specialists may refer to your condition using a variety of terms. Therefore, you should understand that scleroderma is often considered a synonym or a condition closely related to the following:

  • Familial Progressive Systemic Sclerosis

  • Morphea

  • Progressive Systemic Sclerosis

  • Systemic Sclerosis

In addition to synonyms and related conditions, physicians may refer to scleroderma using certain coding systems. The International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) is the most commonly used system of classification for the world's illnesses. Your physician may use this coding system as an administrative or tracking tool. The following classification is commonly used for scleroderma:

  • 710.1 systemic sclerosis

For the purposes of this sourcebook, we have attempted to be as inclusive as possible, looking for official information for all of the synonyms relevant to scleroderma. You may find it useful to refer to synonyms when accessing databases or interacting with healthcare professionals and medical librarians.

Moving Forward

Since the 1980s, the world has seen a proliferation of healthcare guides covering most illnesses. Some are written by patients or their family members. These generally take a layperson's approach to understanding and coping with an illness or disorder. They can be uplifting, encouraging, and highly supportive. Other guides are authored by physicians or other healthcare providers who have a more clinical outlook. Each of these two styles of guide has its purpose and can be quite useful.

As editors, we have chosen a third route. We have chosen to expose you to as many sources of official and peer-reviewed information as practical, for the purpose of educating you about basic and advanced knowledge as recognized by medical science today. You can think of this sourcebook as your personal Internet age reference librarian.

Why “Internet age”? All too often, patients diagnosed with scleroderma will log on to the Internet, type words into a search engine, and receive several Web site listings which are mostly irrelevant or redundant. These patients are left to wonder where the relevant information is, and how to obtain it. Since only the smallest fraction of information dealing with scleroderma is even indexed in search engines, a non-systematic approach often leads to frustration and disappointment. With this sourcebook, we hope to direct you to the information you need that you would not likely find using popular Web directories. Beyond Web listings, in many cases we will reproduce brief summaries or abstracts of available reference materials. These abstracts often contain distilled information on topics of discussion.

While we focus on the more scientific aspects of scleroderma, there is, of course, the emotional side to consider. Later in the sourcebook, we provide a chapter dedicated to helping you find peer groups and associations that can provide additional support beyond research produced by medical science. We hope that the choices we have made give you the most options available in moving forward. In this way, we wish you the best in your efforts to incorporate this educational approach into your treatment plan.

The Editors

 
 

 Words Defined in the Vocabulary Builders

 
 
     
A Exogenous Parasitic
Abdominal Extracellular Parenteral
Aberrant F Penicillamine
Acetaminophen Facial Perioral
Acrodermatitis Fatigue Perivascular
Adjuvant Febrile Pharmacologic
Alimentary Fibroblasts Phenytoin
Alkaline G Phosphorylation
Alleles Gangrene Photochemotherapy
Anemia Gastrointestinal Phototherapy
Angioedema Gels Pigmentation
Anorectal Gingivitis Placenta
Antibiotic Griseofulvin Pneumonia
Antibody H Polypeptide
Anticoagulants Halitosis Porphyria
Antigen Haplotypes Predisposition
Antimicrobial Heartburn Prednisone
Antioxidant Hematocrit Prevalence
Antipruritic Hemorrhage Procollagen
Anxiety Herpes Progeria
Arrhythmia Hoarseness Progressive
Arteries Homologous Proportional
Aspiration Hormones Prostaglandins
Assay Humoral Protease
Atrophy Hybridization Proteins
Autoantigens Hydroxyproline Proximal
Autoimmunity Hyperbaric Psoriasis
B Hyperplasia Pulmonary
Bacteria Hypertension Purpura
Baths Hypothyroidism R
Benign I Receptor
Biliary Idiopathic Recombinant
Bilirubin Iloprost Recurrence
Biochemical Immunochemistry Reflective
Biopsy Impotence Reflux
Bleomycin Induction Reserpine
Bullous Infiltration Resorption
C Inflammation Retinoids
Calcinosis Infusion Rheumatoid
Camptothecin Ingestion Rheumatology
Capillary Interferons Riboflavin
Capsules Interleukins S
Captopril Interstitial Secretion
Carbohydrate Intestines Selenium
Cardiac Intravenous Serum
Cardiomyopathy Ischemia Sialorrhea
Carotene K Soaps
Caustic Keratosis Solvent
Chemotherapy L Spectrum
Cholesterol Larynx Spondylitis
Chronic Lesion Stasis
Cirrhosis Levodopa Stomach
Coagulation Ligament Stomatitis
Colitis Ligation Sunburn
Constipation Lip Sweat
Constitutional Lubrication Symptomatic
Contraception Lupus T
Contracture Lymphoma Teratogenic
Coronary M Testicular
Curcumin Malabsorption Thalidomide
Cutaneous Malignant Thermal
Cytokines Membrane Thermoregulation
Cytomegalovirus Methotrexate Thyrotropin
Cytotoxic Microgram Thyroxine
D Molecular Tolerance
Degenerative Monocytes Topical
Dermatitis Motility Toxic
Dermatosis Mucosa Transcutaneous
Dermis Mutagenesis Transplantation
Diarrhea Myalgia Trichloroethylene
Diffusion Mycosis U
Digestion Myeloma Ulcer
Distal Myocarditis Ulceration
Dystrophy N Urticaria
E Nausea V
Elasticity Necrosis Vaccine
Emollient Neonatal Vaginal
Enalapril Neural Vascular
Endogenous Neurologic Vasculitis
Enzyme Niacin Ventricular
Eosinophilia Nifedipine Vesicular
Eosinophils Nitrogen Viral
Epidemic O Viruses
Epidermal Oral Visceral
Epitopes Osteoporosis X
Epoprostenol Overdose Xerostomia
Erection Oxidation
Esophagitis P
 
 
 
P

A

P

E

R

B

A

C

K

Paperback Book

Paperback Book

Order by phone:

800-843-2665 (within USA)

1-201-272-3651 (from outside USA)


E

B

O

O

K

 

 

Back